Rapport Therapeutics, Inc. (RAPP)
NASDAQ: RAPP · Real-Time Price · USD
48.77
-2.06 (-4.05%)
At close: Aug 28, 2026, 4:00 PM EDT
48.81
+0.04 (0.08%)
After-hours: Aug 28, 2026, 7:30 PM EDT
Rapport Therapeutics Market Cap
Rapport Therapeutics has a market cap or net worth of $2.34 billion as of August 28, 2026. Its market cap has increased by 328.26% in one year.
Market Cap
2.34B
Enterprise Value
1.91B
1-Year Change
328.26%
Ranking
Category
Stock Price
$48.77
ChartMarket Cap Chart
Since the IPO on June 7, 2024, Rapport Therapeutics's market cap has increased from $601.40M to $2.34B, an increase of 289.08%. That is a compound annual growth rate of 84.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2026 | 2.34B | 61.81% |
| Dec 31, 2025 | 1.45B | 122.86% |
| Dec 31, 2024 | 648.87M | 7.89% |
| Jun 7, 2024 | 601.40M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Nektar Therapeutics | 2.46B |
| Trevi Therapeutics | 2.45B |
| Vera Therapeutics | 2.43B |
| Biohaven | 2.41B |
| Kodiak Sciences | 2.41B |
| Nuvation Bio | 2.39B |
| Sarepta Therapeutics | 2.34B |
| Ocular Therapeutix | 2.32B |